SCYX logo
SCYX NASDAQ US

SCYNEXIS, Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO May 2014
$0.89
▲ +$0.00 (+0.00%)
Vol 262K
4
Quality Score
fail
Mkt Cap
$26.5M
ROE
-54.3%
Margin
-862.9%
D/E
0.00
Beta
1.35
52W
$1–$1

Wall Street Consensus

9 analysts · Apr 2026
3
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
88.9%
Buy Rating

Price Chart

Similar Stocks

CPIX
Cumberland Pharmaceuticals Inc
$59.5M
MIRA
MIRA Pharmaceuticals Inc
$63.2M
NTRB
Nutriband Inc
$55.3M
TELO
Telomir Pharmaceuticals Inc
$45.7M
GRCE
Grace Therapeutics, Inc
$53.5M
VERU
Veru Inc
$34.3M
TLPH
Talphera Inc
$53.1M
ANEB
Anebulo Pharmaceuticals Inc
$41.5M

Earnings

Beat rate: 100.0%
Next Report May 13, 2026
EPS Estimate: $-0.12
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.12 — —
Dec 2025 $0.13 $0.24 +$0.11
Sep 2025 $-0.20 $-0.17 +$0.03
Jun 2025 $-0.19 $-0.14 +$0.05

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -37.4% -37.4% -37.4% -37.4% -54.3% -54.3%
P/E (TTM) — — — — — —
Net Margin -504.8% -599.0% -599.0% -599.0% -862.9% -862.9%
Gross Margin — 100.0% 100.0% 100.0% 100.0% 100.0%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 5.20 5.20 5.20 5.20 5.75 5.75

Key Ratios

ROA (TTM)
-37.4%
P/S (TTM)
9.05
P/B
0.8
EPS (TTM)
$-0.51
Rev Growth 3Y
-34.2%
52W High
$1.49
52W Low
$0.57
$0.57 52-Week Range $1.49

How does SCYX compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

SCYX AARD ACB ACRS ADIL

SCYX valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
9.1
▲ 83% above peers (5.0)
vs Peers
vs Industry
Pricier
P/B ratio
0.8
▼ 61% below peers (2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

SCYX profitability vs Pharmaceuticals peers

ROE
-54.3%
▲ 0% above peers (-54.3%)
vs Peers
vs Industry
In line
Net margin
-862.9%
▼ 1722% below peers (-47.4%)
vs Peers
vs Industry
Weak
Gross margin
100.0%
▲ 46% above peers (68.3%)
vs Peers
vs Industry
Below avg
ROA
-37.4%
▲ 0% above peers (-37.4%)
vs Peers
vs Industry
In line

SCYX financial health vs Pharmaceuticals peers

D/E ratio
0.0
▼ 100% below peers (1.5)
vs Peers
vs Industry
Low debt
Current ratio
5.8
▲ 71% above peers (3.4)
vs Peers
vs Industry
Below avg
Beta
1.4
▲ 44% above peers (0.9)
vs Peers
vs Industry
More volatile

SCYX fundamentals radar

SCYX Peer median Industry

SCYX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

SCYX vs peers: key metrics

Latest News

No related news yet